Trump White House Reveals How Many Are Benefiting From the Trump Tax Cuts
Wait, Mamdani Got Cozy With Another Terrorist at a Public Event. The Gracie...
Did You See the Lead Reporter Behind That CNN Article on the NYC...
This State Is About to End Government-Sponsored Kidnapping
Federal Judge Puts Another Snag in Trump Admin's Deportation Efforts
Trump Asked Major GOP Donors Who They Want to Succeed Him. This Is...
Left-Wing Activists Are Training Juries to Sabotage Trump DOJ Cases
A Veteran Had No Family at His Funeral, So America Came Instead
IRS Docs Reveal Jennifer Siebel Newsom Reportedly Pocketed Millions From Her 'Gender Stere...
Report: Shots Fired at the U.S. Consulate in Toronto in 'National Security Incident'
The Left Has Transitioned Away From the Concept of Consent
Parents of Fallen US Soldiers in the Middle East Had One Message for...
Senator Thune Blasts Democrats for Failing at Basic Duties of Government As DHS...
Oil Price Crashes As President Trump Urges Tankers Into the Strait of Hormuz
That Thing the Left Says Never Happens Just Happened Again
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’
AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos